Inhibition of Vascular Endothelial Growth Factor Reduces Scar Formation after Glaucoma Filtration Surgery
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
PURPOSE: Filtration failure due to excessive postoperative scarring remains a major problem after glaucoma surgery. The authors have investigated whether glaucoma and filtration surgery are associated with increased levels of vascular endothelial growth factor (VEGF), and whether a humanized monoclonal antibody against VEGF, bevacizumab, can reduce postoperative scar formation and improve surgical outcome. METHODS: The levels of VEGF in samples of aqueous humor were measured by ELISA. The expression of the VEGF receptors Flt-1 and KDR was analyzed in cultured Tenon fibroblasts by real-time RT-PCR and Western blotting. The effect of VEGF and bevacizumab on Tenon fibroblasts in vitro was determined using a proliferation assay. The in vivo effect of the antibody was investigated in a rabbit model of trabeculectomy by measuring the intraocular pressure (IOP) and bleb area, and by immunohistological analysis of angiogenesis, inflammation, and fibrosis. RESULTS: VEGF levels were increased significantly in the aqueous humor of glaucoma patients and rabbits that had undergone surgery. Both VEGF receptors were expressed on Tenon fibroblasts. Fibroblast proliferation in vitro was stimulated by delivery of VEGF, and was inhibited by administration of bevacizumab. The antibody also reduced angiogenesis and collagen deposition significantly, and improved the outcome of glaucoma surgery in rabbits. CONCLUSIONS: VEGF was upregulated in the aqueous humor of glaucoma patients and in the rabbit model, and it stimulated fibroblast proliferation in vitro. This suggests that it is involved in the scarring process after filtration surgery. Bevacizumab reduced the proliferation of fibroblasts in vitro and improved surgical outcome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bevacizumab is reported to have antifibrotic activity that reduces scar formation in glaucoma filtration surgery.29–31”
From Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials (2014) · cites this paper as [30]
Citations
Cites
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Self-citationAiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001) · Nature Medicine · doi:10.1038/87904 · Cited by 1,672
Self-citationTonnesen, M. G., Feng, X., & Clark, R. A. F. (2000) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2000.00014.x · Cited by 1,463
Stone, J., Itin, A., Alon, T., Pe'er, J., Gnessin, H., Chan-Ling, T., & Keshet, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-04738.1995 · Cited by 1,006
Nissen, N., Polverini, P. J., Koch, A. E., Volin, M. V., Gamelli, R. L., & DiPietro, L. A. (1998) · Europe PMC (PubMed Central) · Cited by 965
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels
Fischer, C., Jonckx, B., Mazzone, M., Zacchigna, S., Loges, S., Pattarini, L., Chorianopoulos, E., Liesenborghs, L., Koch, M., De Mol, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.038 · Cited by 779
Self-citationPertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., & Alitalo, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37365-9 · Cited by 694
Pharmacokinetics of Intravitreal Bevacizumab (Avastin)
Bakri, S. J., Snyder, M. R., Reid, J. M., Pulido, J. S., & Singh, R. J. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.01.017 · Cited by 683
Aqueous Humor in Glaucomatous Eyes Contains an Increased Level of TGF-β2
Tripathi, R. C., Li, J., Chan, W. A., & Tripathi, B. J. (1994) · Experimental Eye Research · doi:10.1006/exer.1994.1158 · Cited by 566
Cited by
Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials
Daniel, E., Toth, C. A., Grunwald, J. E., Jaffe, G. J., Martin, D. F., Fine, S. L., Huang, J., Ying, G.-S., Hagstrom, S. A., Winter, K., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.10.019 · Cited by 335
PCL-PEG copolymer based injectable thermosensitive hydrogels
Dethe, M. R., A, P., Ahmed, H., Agrawal, M., Roy, U., & Alexander, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.035 · Cited by 263
Propolis: An update on its chemistry and pharmacological applications
Hossain, R., Quispe, C., Khan, R. A., Saikat, A. S. M., Ray, P., Ongalbek, D., Yeskaliyeva, B., Jain, D., Smeriglio, A., Trombetta, D., et al. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00651-2 · Cited by 215
Research progress on the mechanism of angiogenesis in wound repair and regeneration
Shi, Z., Yao, C., Shui, Y., Li, S., & Yan, H. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1284981 · Cited by 183
The surgical management of glaucoma: A review
Lim, R. (2022) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.14028 · Cited by 179
Targeting VEGF in eye neovascularization: What's new?
Amadio, M., Govoni, S., & Pascale, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.027 · Cited by 175
Conjunctival fibrosis following filtering glaucoma surgery
Schlunck, G., Meyer-ter-Vehn, T., Klink, T., & Grehn, F. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.03.021 · Cited by 175
Wound Modulation After Filtration Surgery
Seibold, L. K., Sherwood, M. B., & Kahook, M. Y. (2012) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.01.008 · Cited by 167
Tseng, J., Vance, S. K., Torre, K. E. D., Mendonça, L. S., Cooney, M. J., Klancnik, J. M., Sorenson, J. A., & Freund, K. B. (2011) · Journal of Glaucoma · doi:10.1097/ijg.0b013e31820d7d19 · Cited by 146
Subconjunctival Bevacizumab Versus Mitomycin C Adjunctive to Trabeculectomy
Nilforushan, N., Yadgari, M., Kish, S. K., & Nassiri, N. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.08.005 · Cited by 128
Modulation of Fibroblasts in Conjunctival Wound Healing
Zada, M., Pattamatta, U., & White, A. J. R. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.08.028 · Cited by 114
Jacob, A., Parolia, A., Pau, A. K. H., & Davamani, F. A. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0814-1 · Cited by 113
Sergeys, J., Etienne, I., Hove, I. V., Lefevere, E., Stalmans, I., Feyen, J. H. M., Moons, L., & Bergen, T. V. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-25372 · Cited by 106
Self-citationHolló, G. (2017) · Developments in ophthalmology · doi:10.1159/000458488 · Cited by 97
The role of different VEGF isoforms in scar formation after glaucoma filtration surgery
Bergen, T. V., Vandewalle, E., de Veire, S. V., Dewerchin, M. A., Stassen, J., Moons, L., & Stalmans, I. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.08.016 · Cited by 93
Self-citationNanotechnology for Medical and Surgical Glaucoma Therapy—A Review
Occhiutto, M. L., Maranhão, R. C., Costa, V. P., & Konstas, A. G. P. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01163-6 · Cited by 91
VEGF Induces TGF-β1 Expression and Myofibroblast Transformation after Glaucoma Surgery
Park, H. L., Kim, J., & Park, C. K. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.009 · Cited by 82
Electrospun formulations of bevacizumab for sustained release in the eye
Angkawinitwong, U., Awwad, S., Khaw, P. T., Brocchini, S., & Williams, G. R. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.10.015 · Cited by 77
Lockwood, A., Brocchini, S., & Khaw, P. T. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.10.008 · Cited by 74
Intracameral bevacizumab as an adjunct to trabeculectomy: a 1-year prospective, randomised study
Vandewalle, E., Pinto, L. A., Bergen, T. V., Spielberg, L. H., Fieuws, S., Moons, L., Spileers, W., Zeyen, T. G., & Stalmans, I. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-303966 · Cited by 74
Self-citationAntifibrotic activity of bevacizumab on human Tenon's fibroblasts in vitro
O'Neill, E. C., Qin, Q., Van Bergen, N. J., Connell, P. P., Vasudevan, S., Coote, M. A., Trounce, I. A., Wong, T. T. L., & Crowston, J. G. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5669 · Cited by 73
Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions
Rahić, O., Tucak, A., Omerović, N., Sirbubalo, M., Hindija, L., Hadžiabdić, J., & Vranić, E. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010028 · Cited by 73
Current and Future Techniques in Wound Healing Modulation after Glaucoma Filtering Surgeries
Masoumpour, M. B., Nowroozzadeh, M. H., & Razeghinejad, R. (2016) · The Open Ophthalmology Journal · doi:10.2174/1874364101610010068 · Cited by 70
Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review
Kim, M., Lee, C., Payne, R. M., Yue, B. Y. J. T., Chang, J.-H., & Ying, H. (2015) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2015.04.003 · Cited by 69
Xi, L., Wang, T., Zhao, F., Zheng, Q., Li, X., Luo, J., Liu, J., Quan, D., & Ge, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100632 · Cited by 63
Tear Cytokine Profile in Medicated Glaucoma Patients
Chong, R. S., Jiang, Y., Boey, P. Y., Yu, S. J., Htoon, H. M., Aung, T., Khaw, P. T., & Wong, T. T. L. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.03.064 · Cited by 61
Yang, L., Lan, Y., Guo, H., Cheng, L.-Z., Fan, J., Cai, X., Zhang, L., Chen, R., & Zhou, H.-S. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.125 · Cited by 61
Zadorozhna, M., Gioia, S. D., Conese, M., & Mangieri, D. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05290-0 · Cited by 60
Novel Therapies for the Prevention of Fibrosis in Glaucoma Filtration Surgery
Shao, C. G., Sinha, N. R., Mohan, R. R., & Webel, A. D. (2023) · Biomedicines · doi:10.3390/biomedicines11030657 · Cited by 60
Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations
Shen, J., Lu, G. W., & Hughes, P. M. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2498-y · Cited by 59
Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Andrés‐Guerrero, V., Perucho-Gonzalez, L., Garcia-Sanchez, J., Morales‐Fernández, L., Saenz-Frances, F., Herrero‐Vanrell, R., Pablo, L. E., Polo, V., Martínez-de-la-Casa, J. M., & Konstas, A.-G. P. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0461-z · Cited by 59
Trabeculectomy: A Brief History and Review of Current Trends
Koike, K. J., & Chang, P. T. S. (2018) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000231 · Cited by 59
Akkan, J. C. U., & Cilsim, S. (2013) · Journal of Glaucoma · doi:10.1097/ijg.0b013e318287abf3 · Cited by 58
Improving patient outcomes following glaucoma surgery: state of the art and future perspectives
Bergen, T. V., de Velde, S. V., Vandewalle, E., Moons, L., & Stalmans, I. (2014) · Clinical ophthalmology · doi:10.2147/opth.s48745 · Cited by 57
Self-citationLevel of Vascular Endothelial Growth Factor in Tenon Tissue and Results of Glaucoma Surgery
Park, H.-Y. L., Kim, J., Ahn, M. D., & Park, C. K. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.2799 · Cited by 57
Hollanders, K., Bergen, T. V., Kindt, N., Castermans, K., Leysen, D. C., Vandewalle, E., Moons, L., & Stalmans, I. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15681 · Cited by 55
Self-citationKhaw, P. T., Bouremel, Y., Brocchini, S., & Henein, C. (2020) · Eye · doi:10.1038/s41433-020-1031-9 · Cited by 52
de Velde, S. V., Bergen, T. V., Vandewalle, E., Kindt, N., Castermans, K., Moons, L., & Stalmans, I. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.04.014 · Cited by 52
Self-citationLiu, L., Xu, Y., Huang, Z., & Wang, X. (2016) · BMC Ophthalmology · doi:10.1186/s12886-016-0248-7 · Cited by 50
Vera, V., Sheybani, A., Lindfield, D., Stalmans, I., & Ahmed, I. I. K. (2019) · Clinical ophthalmology · doi:10.2147/opth.s195457 · Cited by 49
Self-citationYu‐Wai‐Man, C., & Khaw, P. T. (2014) · Expert Review of Ophthalmology · doi:10.1586/17469899.2015.983475 · Cited by 46
Anti–Vascular Endothelial Growth Factor Therapy in Glaucoma Filtration Surgery
Mathew, R. G., & Barton, K. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.03.013 · Cited by 43
Inhibition of placental growth factor improves surgical outcome of glaucoma surgery
Bergen, T. V., Jonckx, B., Hollanders, K., Sijnave, D., de Velde, S. V., Vandewalle, E., Moons, L., Stassen, J., & Stalmans, I. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12151 · Cited by 42
Self-citationBleb vascularity following post‐trabeculectomy subconjunctival bevacizumab: a pilot study
Chua, B., Nguyen, D. Q., Qin, Q., Ruddle, J. B., Wells, A. P., Niyadurupola, N., Gupta, V., Wong, T. T. L., Coote, M., & Crowston, J. G. (2012) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2012.02798.x · Cited by 41
Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery
Cheng, J.-W., Cheng, S., Wei, R.-L., & Lu, G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009782.pub2 · Cited by 40
Glaucoma Treatment and Hydrogel: Current Insights and State of the Art
Fea, A. M., Novarese, C., Caselgrandi, P., & Boscia, G. (2022) · Gels · doi:10.3390/gels8080510 · Cited by 40
Liarakos, V. S., Papaconstantinou, D., Vergados, I. A., Douvali, M., & THEODOSSIADIS, P. G. (2013) · European Journal of Ophthalmology · doi:10.5301/ejo.5000391 · Cited by 39
The Role of the MRTF-A/SRF Pathway in Ocular Fibrosis
Yu‐Wai‐Man, C., Treisman, R., Bailly, M., & Khaw, P. T. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14692 · Cited by 37
Surgical Treatment of Canine Glaucoma
Bras, D., & Maggio, F. (2015) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2015.06.007 · Cited by 35
Freiberg, F. J., Matlach, J., Grehn, F. J., Klink, & Karl, K. (2013) · Clinical ophthalmology · doi:10.2147/opth.s41750 · Cited by 34
Use of Anti-VEGF Agents in Glaucoma Surgery
Slabaugh, M. A., & Salim, S. (2017) · Journal of Ophthalmology · doi:10.1155/2017/1645269 · Cited by 34
Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab
Park, S. C., Su, D., & Tello, C. A. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.721772 · Cited by 33
Tissue Response to Implanted Ahmed Glaucoma Valve with Adjunctive Amniotic Membrane in Rabbit Eyes
Lee, J. W., Park, W. Y., Kim, E., & Yun, I. H. (2014) · Ophthalmic Research · doi:10.1159/000357097 · Cited by 33
Han, Q., Wang, Y., Li, X., Peng, R., Li, A., Qian, Z., & Yu, L. (2015) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-015-5556-6 · Cited by 33
Anti-VEGF Agents with or without Antimetabolites in Trabeculectomy for Glaucoma: A Meta-Analysis
Xiong, Q., Li, Z., Li, Z., Zhu, Y., Abdulhalim, S., Wang, P., & Cai, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088403 · Cited by 33
Self-citationBevacizumab Revisited: Its Use in Different Mouse Models of Ocular Pathologies
Hollanders, K., Bergen, T. V., de Velde, S. V., Sijnave, D., Vandewalle, E., Moons, L., & Stalmans, I. (2014) · Current Eye Research · doi:10.3109/02713683.2014.943910 · Cited by 33
Self-citationSurgical Treatment of Canine Glaucoma
Maggio, F., & Bras, D. (2015) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2015.06.008 · Cited by 33
Özdemir, Ö., Altıntaş, Ö., Altıntaş, L., Özkan, B., Koçer, Ç. A., & Yüksel, N. (2014) · Arquivos Brasileiros de Oftalmologia · doi:10.5935/0004-2749.20140054 · Cited by 33
Bergen, T. V., Vandewalle, E., Moons, L., & Stalmans, I. (2015) · Acta Ophthalmologica · doi:10.1111/aos.12766 · Cited by 33
Self-citationKiddee, W., Orapiriyakul, L., Kittigoonpaisan, K., Tantisarasart, T., & Wangsupadilok, B. (2014) · Journal of Glaucoma · doi:10.1097/ijg.0000000000000194 · Cited by 32
Liu, X., Du, L., & Li, N. (2016) · Medicine · doi:10.1097/md.0000000000003223 · Cited by 32
Gajda-Deryło, B., Stahnke, T., Struckmann, S., Warsow, G., Birke, K., Birke, M. T., Hohberger, B., Ręjdak, R., Fuellen, G., & Jünemann, A. G. M. (2019) · Bioscience Reports · doi:10.1042/bsr20181894 · Cited by 31
The Effect of Bevacizumab on Wound Healing Modulation in an Experimental Trabeculectomy Model
Özgönül, C., Mumcuoğlu, T., & Günal, A. (2013) · Current Eye Research · doi:10.3109/02713683.2013.851704 · Cited by 31
Min, J., Lukowski, Z. L., Levine, M. A., Meyers, C., Beattie, A. R., Schultz, G. S., Samuelson, D. A., & Sherwood, M. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035627 · Cited by 30
Liu, Y., Kimura, K., Orita, T., Teranishi, S., 鈴木, 克., & Sonoda, K. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13572 · Cited by 30
Choi, J., Choi, J., & Kim, Y.-D. (2010) · Korean Journal of Ophthalmology · doi:10.3341/kjo.2010.24.1.47 · Cited by 29
Seet, L., Narayanaswamy, A., Finger, S. N., Htoon, H. M., Nongpiur, M. E., Toh, L. Z., Ho, H., Perera, S., & Wong, T. T. L. (2016) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12743 · Cited by 28
Paula, J. S., Ribeiro, V. R. C., Chahud, F., Cannellini, R., Monteiro, T. C., Gomes, E. C. D. L., Reinach, P. S., Rodrigues, M. D. L. V., & Silva‐Cunha, A. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0136 · Cited by 28
Vahedian, Z., Mafi, M., Fakhraie, G., Zarei, R., Eslami, Y., Ghadimi, H., & Mohebbi, M. (2017) · Journal of Glaucoma · doi:10.1097/ijg.0000000000000741 · Cited by 27
The Effect of Bevacizumab on the Outcome of Trabeculectomy with 5-Fluorouracil
Suh, W., & Kee, C. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0250 · Cited by 27
Experimental models of glaucoma filtration surgery
Chong, R. S., Crowston, J. G., & Wong, T. T. L. (2020) · Acta Ophthalmologica · doi:10.1111/aos.14485 · Cited by 27
Butler, M. R., Ponce, C. M. P., Weinstock, Y. E., Orengo-Nania, S. D., Chévez‐Barrios, P., & Frankfort, B. J. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12047 · Cited by 27
Sijnave, D., Bergen, T. V., Castermans, K., Kindt, N., Vandewalle, E., Stassen, J., Moons, L., & Stalmans, I. (2015) · Cornea · doi:10.1097/ico.0000000000000493 · Cited by 27
Self-citationThe PLGA Implant as an Antimitotic Delivery System After Experimental Trabeculectomy
Rodríguez-Agirretxe, I., Vega, S. C., Rezola, R., Vecino, E., Mendicute, J., Suarez-Cortes, T. M., & Acera, A. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-11777 · Cited by 26
Şimşek, T., Çankaya, A. B., & Elgin, U. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0035 · Cited by 26
Sandberg, C. A., Herring, I. P., Huckle, W. R., LeRoith, T., Pickett, J. P., & Rossmeisl, J. H. (2011) · Veterinary Ophthalmology · doi:10.1111/j.1463-5224.2011.00931.x · Cited by 25
Peng, R., Qin, G., Li, X., Lv, H., Qian, Z., & Yu, L. (2014) · Medical Hypothesis Discovery & Innovation in Ophthalmology · Cited by 24
Fakhraie, G., Ghadimi, H., Eslami, Y., Zarei, R., Mohammadi, M., Vahedian, Z., Mafi, M., & Moghimi, S. (2014) · Journal of Glaucoma · doi:10.1097/ijg.0000000000000202 · Cited by 24
Igarashi, N., Honjo, M., Kurano, M., Yatomi, Y., Igarashi, K., Kano, K., Aoki, J., & Aihara, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-29649-3 · Cited by 23
Mahale, A. M., Fikri, F., Hati, K. A., Shahwan, S. A., Jadaan, I. A., Katan, H. A., Khandekar, R. B., Maktabi, A. M., & Edward, D. P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187506 · Cited by 22
Overview of cicatricial modulators in glaucoma fistulizing surgery
de Oliveira, C. M., & Ferreira, J. D. L. M. (2020) · International Ophthalmology · doi:10.1007/s10792-020-01454-w · Cited by 22
Connexin43 Modulation Inhibits Scarring in a Rabbit Eye Glaucoma Trabeculectomy Model
Deva, N. C., Zhang, J., Green, C. R., & Danesh-Meyer, H. V. (2012) · Inflammation · doi:10.1007/s10753-012-9439-4 · Cited by 22
Takeuchi, K., Nakazawa, M., & Ebina, Y. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7478 · Cited by 22
Wound Healing Response After Bleb-Forming Glaucoma Surgery With a SIBS Microshunt in Rabbits
van Mechelen, R. J. S., Wolters, J. E. J., Herfs, M., Bertens, C. J. F., Gijbels, M. J., Pinchuk, L., Gorgels, T. G. M. F., & Beckers, H. J. M. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.8.29 · Cited by 22
Modulation of wound healing in glaucoma surgery
de Velde, S. V., Bergen, T. V., Vandewalle, E., Moons, L., & Stalmans, I. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.05.002 · Cited by 21
Self-citationChatterjee, S., Wang, Y., Duncan, M. K., & Naik, U. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063674 · Cited by 21
Anti-vascular endothelial growth factor therapies in ophthalmology
Köksaldı, S., Kartı, Ö., & Saatçi, A. O. (2025) · Medical Hypothesis Discovery & Innovation in Ophthalmology · doi:10.51329/mehdiophthal1526 · Cited by 21
Deep Sclerectomy With Bevacizumab and Mitomycin C: A Comparative Study
Anand, N., & Bong, C. X. (2013) · Journal of Glaucoma · doi:10.1097/ijg.0b013e3182883c0c · Cited by 21
Adjunctive Bevacizumab in Patients Undergoing Ahmed Valve Implantation: A Pilot Study
Rojo-Arnao, M., Albis-Donado, O., Lliteras-Cardin, M., Kahook, M. Y., & Gil‐Carrasco, F. (2011) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/15428877-20110316-02 · Cited by 21
Effects of mammalian target of rapamycin inhibitors on fibrosis after trabeculectomy
Igarashi, N., Honjo, M., & Aihara, M. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108421 · Cited by 19
Saeed, A. M., & Aboulnasr, T. (2014) · Clinical ophthalmology · doi:10.2147/opth.s67730 · Cited by 19
Intravitreal ranibizumab as an adjunct for Ahmed valve surgery in open‐angle glaucoma: a pilot study
Desai, R. U., Singh, K., & Lin, S. C. (2012) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2012.02836.x · Cited by 18
Mello, G. R., Pizzolatti, M. L., Wasilewski, D., de Santhiago, M. R., Budel, V. M., & Moreira, H. (2011) · Clinics · doi:10.1590/s1807-59322011000800023 · Cited by 18
Liu, Y., Kimura, K., Orita, T., 鈴木, 克., Teranishi, S., Mori, T., & Sonoda, K. H. (2015) · PubMed Central · Cited by 17
Wang, Y., Xu, Z., Li, W., Wei, W., Qin, M., Li, Q., Liu, X., Zhang, X., & Wang, X. (2022) · Biomaterials Science · doi:10.1039/d1bm01614h · Cited by 17
Zhang, Y., Zhu, S., Xu, X., & Zuo, L. (2019) · Journal of Ophthalmology · doi:10.1155/2019/7419571 · Cited by 17
Landers, J. A., Mullany, S., & Craig, J. E. (2023) · British Journal of Ophthalmology · doi:10.1136/bjo-2023-323526 · Cited by 16
Yoshida, M., Kokubun, T., Sato, K., Tsuda, S., Yokoyama, Y., Himori, N., & Nakazawa, T. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.10.2 · Cited by 16
Nilforushan, N., Es’haghi, A., Miraftabi, A., Abolfathzadeh, N., & Banifatemi, M. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-317324 · Cited by 16
Clinical use of Bevacizumab in treating refractory glaucoma.
Popescu, V., Pricopie, S., Totir, M., Iancu, R., Yasyn, S., & Alexandrescu, C. (2015) · PubMed Central · Cited by 15
Metadata
- Authors
- Li, Z., Van Bergen, T., Van de Veire, S., Van de Vel, I., Moreau, H., Dewerchin, M., Maudgal, P. C., Zeyen, T., Spileers, W., Moons, L., & Stalmans, I.
- Affiliations
- Capital Medical University (CN)
- From the Laboratory of Ophthalmology, and
- From the Laboratory of Ophthalmology, and 4Department of Ophthalmology, University Hospitals Leuven, Leuven, Belgium;
- ThromboGenics NV, Leuven, Belgium;
- Vlaams Instituut voor Biotechnologie (BE)
- Universitair Ziekenhuis Leuven (BE)
- KU Leuven (BE)
- Corresponding author
- Li, Zhongqiu
- Moreau, Huberte
- Dewerchin, Mieke
- Maudgal, Prabhat C.
- Zeyen, Thierry
- Spileers, Werner
- Moons, Lieve
- Stalmans, Ingeborg
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2009-11-01
- Volume
- 50
- Issue
- 11
- Pages
- 5217
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2004845166
- Cited by
- 223
- References
- 55
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 5 · 2023: 19 · 2022: 11 · 2021: 9 · 2020: 18 · 2019: 16 · 2018: 11 · 2017: 16 · 2016: 16 · 2015: 19 · 2014: 18 · 2013: 18 · 2012: 19
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion)
- Funders
- U.S. Food and Drug Administration
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Corneal surgery and disorders
- Health Sciences › Medicine › Ophthalmology › Intraocular Surgery and Lenses
- Keywords
- vascular endothelial growth factor, bevacizumab, glaucoma filtration surgery, trabeculectomy, postoperative scarring, aqueous humor, Tenon fibroblasts, VEGF receptors, angiogenesis, fibrosis, collagen deposition, intraocular pressure, blebs
- MeSH terms
- Bevacizumab, Animals, Anterior Chamber, Antibodies, Monoclonal, Aqueous Humor, Cells, Cultured, Cicatrix, Conjunctival Diseases, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Female, Fibroblasts, Glaucoma, Open-Angle, Humans, Injections, Intraocular Pressure, Postoperative Complications, Rabbits, Tonometry, Ocular, Trabeculectomy, Reverse Transcriptase Polymerase Chain Reaction, Angiogenesis Inhibitors, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-1, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Cell Proliferation, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.